Myeloid Neoplasm Post Cytotoxic Therapy

Preferred Label : Myeloid Neoplasm Post Cytotoxic Therapy;

NCIt synonyms : Therapy-Related AML and MDS; Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome; Acute Myeloid Leukaemias and Myelodysplastic Syndromes, Therapy-Related;

NCIt related terms : Therapy related myeloid neoplasm; Therapy-related Myeloid Neoplasms; Therapy-Related Myeloid Neoplasm;

NCIt definition : Acute myeloid leukemias, myelodysplastic syndromes, and myelodysplastic/myeloproliferative neoplasms arising as a result of the mutagenic effect of chemotherapy agents and/or radiation that are used for the treatment of neoplastic or non-neoplastic disorders.;

Neoplastic status : Malignant;

ICD-O code : 9920/3;

Details

Origin ID

C27912;

UMLS CUI

C1292776;

Automatic exact mappings (from CISMeF team)
- Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) [SNOMED CT concept]
- Therapy related myeloid neoplasm [ICD-11 Extension code]
- Therapy-related myeloid neoplasms [ICD-11 Subcategory]
Currated CISMeF NLP mapping
- Therapy related acute myeloid leukemia and myelodysplastic syndrome [ORDO Disease]
- Therapy-related acute myeloid leukemia and myelodysplastic syndrome (morphologic abnormality) [Inactive SNOMED CT concept]
Has associated anatomic sites
- Bone Marrow [NCIt concept]
- Hematopoietic and Lymphatic System [NCIt concept]
Semantic type(s)
- Neoplastic Process [UMLS semantic type]
UMLS correspondences (same concept)
- Myeloid neoplasm post cytotoxic therapy (morphologic abnormality) [SNOMED CT concept]
- Therapy related acute myeloid leukemia and myelodysplastic syndrome [ORDO Disease]
- Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) [SNOMED CT concept]
- Therapy-related acute myeloid leukemia and myelodysplastic syndrome (morphologic abnormality) [Inactive SNOMED CT concept]
- Therapy-related acute myeloid leukemia and myelodysplastic syndrome, topoisomerase type II inhibitor-related type (morphologic abnormality) [SNOMED CT concept]
concept_is_in_subset
- AML Authorized Value Terminology [NCIt concept]
- AML Disease Characteristics Table [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- Mapped ICDO3.1 Morphology PT Terminology [NCIt concept]
- Mapped ICDO3.1 Morphology Terminology [NCIt concept]
- Mapped ICDO3.1 Terminology [NCIt concept]
- Mapped ICDO3.2 Morphology PT Terminology [NCIt concept]
- Mapped ICDO3.2 Morphology Terminology [NCIt concept]
- Mapped ICDO3.2 Terminology [NCIt concept]
- NICHD Terminology [NCIt concept]
- Pediatric Hematology-Oncology Terminology [NCIt concept]
disease_excludes_finding
- Benign Cellular Infiltrate [NCIt concept]
disease_has_abnormal_cell
- Malignant Cell [NCIt concept]
- Neoplastic Cell [NCIt concept]
- Neoplastic Hematopoietic and Lymphoid Cell [NCIt concept]
- Neoplastic Myeloid Cell [NCIt concept]
disease_has_finding
- Ineffective Hematopoiesis [NCIt concept]
- Malignant Cellular Infiltrate [NCIt concept]
- Secondary Lesion [NCIt concept]
- Therapy-Related Toxicity [NCIt concept]
disease_has_normal_cell_origin
- Bone Marrow Stem Cell [NCIt concept]
- Hematopoietic and Lymphoid Cell [NCIt concept]
disease_has_normal_tissue_origin
- Hematopoietic Tissue [NCIt concept]
- Hematopoietic and Lymphoid Tissue [NCIt concept]
disease_has_primary_anatomic_site
- Bone Marrow [NCIt concept]
- Hematopoietic and Lymphatic System [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients